Great Lakes Advisors’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Great Lakes Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-18,926	Closed	-$1.18M	–	554
2015 Q1	$1.18M	Sell	18,926 -59	-0.3%	-$3.43K	0.04%	305
2014 Q4	$1.09M	Buy	18,985 +2,374	+14%	+$132K	0.03%	300
2014 Q3	$893K	Buy	16,611 +609	+4%	+$32.3K	0.03%	320
2014 Q2	$839K	Buy	16,002 +653	+4%	+$33.4K	0.03%	212
2014 Q1	$811K	Sell	15,349 -214	-1%	-$9.89K	0.04%	216
2013 Q4	$623K	Buy	15,563 +1,940	+14%	+$76.4K	0.03%	210
2013 Q3	$515K	Buy	13,623 +1,440	+12%	+$56.2K	0.02%	240
2013 Q2	$478K	Buy	+12,183	New	+$474K	0.02%	239

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Great Lakes Advisors's TEVA Position: Q2 2015 in Review

Great Lakes Advisors sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q2 2015, closing a stake of 18,926 shares — an estimated $1.18M sold.

Great Lakes Advisors first reported a position in TEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.18M in Q1 2015. 819 funds tracked by Wall St. Rank hold TEVA as of Q2 2015.

Great Lakes Advisors reported no remaining Teva Pharmaceutical Industries Limited position as of Q2 2015 after selling out during the quarter.
Great Lakes Advisors sold 18,926 Teva Pharmaceutical Industries Limited shares in Q2 2015, an estimated $1.18M.
Great Lakes Advisors first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 8 quarters.
Great Lakes Advisors's Teva Pharmaceutical Industries Limited position peaked at $1.18M in Q1 2015.
819 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2015.

Based on Great Lakes Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.